Hippocampal atrophy, as evidenced using magnetic resonance imaging (MRI), is one of the
most validated, easily accessible and widely used biomarkers of Alzheimer’s disease (AD). …

Introduction It is unclear how different proteinopathies (tau, transactive response DNA‐binding
protein 43 [TDP‐43], amyloid β [Aβ], and α‐synuclein) contribute to atrophy within medial …

Growing interest has developed in hippocampal subfield volumetry over the past few years
and an increasing number of studies use the automatic segmentation algorithm implemented …

The medial temporal lobe (MTL) is connected to the rest of the brain through two main networks:
the anterior-temporal (AT) and the posterior-medial (PM) systems. Given the crucial role …

Medial temporal lobe (MTL) substructures are the earliest regions affected by neurofibrillary
tangle pathology—and thus are promising biomarkers for Alzheimer's disease (AD). …

Recent studies in mouse models of Alzheimer's disease (AD) and in humans suggest that
sleep disruption and amyloid-beta (Aβ) accumulation are interrelated, and may, thus, …

Spurred by availability of automatic segmentation software, in vivo MRI investigations of human
hippocampal subfield volumes have proliferated in the recent years. However, a majority …

… Robin de Flores INSERM U1077, Université de Caen Normandie, UMR-S1077, Ecole …
This variability complicates meaningful comparison of results between studies (de Flores et al., …

Introduction White matter hyperintensities (WMH) are often described in Alzheimer's
disease (AD), but their topography and specific relationships with cognition remain unclear. …

Background: Subjective cognitive decline (SCD) may be the first clinical sign of Alzheimer’s
disease (AD). SCD individuals with normal cognition may already have significant …